In Q1 FY2026, Strata Critical Medical reported revenue of $67.4 million, up 87.4% year-over-year. Net income was $2.2 million, a 161.7% increase, while operating income was negative $3.0 million, improving 47.7%. Diluted EPS was $0.03, up 175% from the prior year. The company held $58.7 million in cash and $285.7 million in equity.
•Revenue grew 87.4% YoY to $67.4 million.
•Net income turned positive at $2.2 million, up 161.7%.
•Operating loss narrowed 47.7% to $3.0 million.
•Diluted EPS rose 175% to $0.03.
Informational summary based on SEC XBRL figures · generated by deepseek-v4-flash. Not investment advice.
Strata Critical Medical provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services
Transplant clinical services, including organ recovery procedures, normothermic regional perfusion, and preservation services other clinical services comprising cardiac perfusion services, blood management and autotransfusion services, extracorporeal membrane oxygenation services, perfusion staffing, and equipment rentals. Founded in 2014 and headquartered in New York, New York, the company was formerly known as Blade Air Mobility, Inc. before rebranding in August 2025.
What does Strata Critical Medical, Inc. (SRTA) do?
Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. The company operates through two segments: Logistics and Clinical. The Logistics segment offers air and ground transportation for human organs, transplant teams, and related medical materials, as well as organ placement services. The Clinical segment provides transplant clinical services such as organ recovery procedures, normothermic regional perfusion, and preservation services. Additionally, it offers other clinical services including cardiac perfusion services, blood management and autotransfusion services, extracorporeal membrane oxygenation (ECMO) services, perfusion staffing, and equipment rentals. The company was formerly known as Blade Air Mobility, Inc. before rebranding in August 2025.
Where is Strata Critical Medical (SRTA) listed and what currency does it trade in?
Strata Critical Medical, Inc. is listed on the Nasdaq Capital Market (NasdaqCM) under the ticker symbol SRTA. Its securities trade in United States Dollars (USD). The company is headquartered in New York, New York, and primarily serves the healthcare industry within the United States.
What sector and industry does Strata Critical Medical (SRTA) belong to?
Strata Critical Medical, Inc. operates in the Healthcare sector, specifically within the Medical Care Facilities industry. This classification reflects its focus on providing critical medical services and logistics support to healthcare providers, including hospitals and transplant centers. The company's services are essential for time-sensitive medical procedures such as organ transplants and emergency medical transport.
Where is Strata Critical Medical (SRTA) headquartered and what markets does it serve?
Strata Critical Medical, Inc. is headquartered in New York, New York, United States. The company serves the healthcare industry across the United States, providing time-critical logistics and medical services. Its operations include air and ground transportation for human organs and transplant teams, as well as clinical services like organ recovery and perfusion. The company's services are utilized by hospitals, transplant centers, and other medical facilities nationwide.
How does Strata Critical Medical (SRTA) generate revenue?
Strata Critical Medical generates revenue through its two operating segments: Logistics and Clinical. The Logistics segment earns revenue by providing air and ground transportation for human organs, transplant teams, and medical materials, as well as organ placement services. The Clinical segment generates revenue from transplant clinical services such as organ recovery procedures, normothermic regional perfusion, and preservation services. Additionally, it offers other clinical services including cardiac perfusion, blood management and autotransfusion, ECMO services, perfusion staffing, and equipment rentals. The company was founded in 2014 and rebranded from Blade Air Mobility, Inc. in August 2025.